drugset / Trial / NCT00106808
Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to compare Muraglitazar and Pioglitazone in patients with Type 2 Diabetes. Both the safety and blood sugar lowering effects of these treatments will be studied.
Timeline
- Start
- 2005-08
- Primary completion
- 2006-08
- Completion
- 2006-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Muraglitazar | Small molecule | — | — |
| Subject | Pioglitazone | Small molecule | — | — |